JENNIFER ALTAMIRA: Open Payments
NPI 1205815248 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 35 payments from 16 companies in 2025. Trend: 2023 $1,209 · 2024 $1,139 · 2025 $1,761
Food & beverage: $1,458Travel & lodging: $303
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $488 |
| Bard Peripheral Vascular, Inc. | 2 | $303 |
| Edwards Lifesciences Corporation | 1 | $212 |
| Novartis Pharmaceuticals Corporation | 9 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $139 |
| E.R. Squibb & Sons, L.L.C. | 5 | $91 |
| Amgen Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $45 |
| PFIZER INC. | 2 | $44 |
| BridgeBio Pharma, Inc. | 2 | $39 |
Products named: Rapiblyk, RotarexS 6 F x 135 cm, SAPIEN 3 Ultra RESILIA, LEQVIO, JARDIANCE, Repatha, CAMZYOS, VYNDAQEL.
Industry payments across CA — which companies pay providers there.
